The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

CONSIDERATIONS OF THE UTILITY OF A DRUG (MEPAZINE) IN A THERAPEUTIC MILIEU

Published Online:https://doi.org/10.1176/ajp.115.1.66

The occurrence of changes in association with the administration of mepazine (Pacatal) to 101 schizophrenic inpatients has been studied. These patients were functioning in the community prior to their admission. Changes considered as improvement within the ward milieu during the period of drug administration occurred in association with effects of the drug in 25 patients. Thirty-four patients experienced improvement in their interpersonal transactions in the ward milieu in the absence of association with drug effects. A somewhat consistent group of interpersonal changes appeared in some patients in association with the drug effects. These data suggest further study of the interpersonal effects, problems and usefulness of these behaviors. The effects associated with the drug offered utility in some of the patients in the therapeutic milieu of the psychiatric unit studied.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.